VDA

シグナル伝達経路

研究分野

  • 阻害剤の選択性比較
  • 溶解度
カタログ番号 製品カタログ 溶解度(25°C)
DMSO アルコール
S1537 DMXAA (Vadimezan) <1 mg/mL 7 mg/mL <1 mg/mL
S1786 Verteporfin <1 mg/mL 100 mg/mL <1 mg/mL
S1176 Plinabulin (NPI-2358) <1 mg/mL 54 mg/mL <1 mg/mL

VDA製品

製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S1537

DMXAA (Vadimezan)

DMXAA (Vadimezan) is a vascular disrupting agents (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 μM and IC50 of 62.5 μM in cell-free assays, respectively. Phase 3.

S1786

Verteporfin

Verteporfin is a small molecule that inhibits TEAD–YAP association and YAP-induced liver overgrowth. It is also a potent second-generation photosensitizing agent derived from porphyrin.

S1176

Plinabulin (NPI-2358)

Plinabulin (NPI-2358) is a vascular disrupting agent (VDA) against tubulin-depolymerizing with IC50 of 9.8~18 nM in tumor cells. Phase 1/2.

製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S1537

DMXAA (Vadimezan)

DMXAA (Vadimezan) is a vascular disrupting agents (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 μM and IC50 of 62.5 μM in cell-free assays, respectively. Phase 3.

2015, 194(9):4477-88

2016, 196(7):3191-8

2015, 194(9):4477-88

S1786

Verteporfin

Verteporfin is a small molecule that inhibits TEAD–YAP association and YAP-induced liver overgrowth. It is also a potent second-generation photosensitizing agent derived from porphyrin.

2014, 211(11):2249-63

2016, 10.1158/1078-0432

2017, 7(5):1114-1132

S1176

Plinabulin (NPI-2358)

Plinabulin (NPI-2358) is a vascular disrupting agent (VDA) against tubulin-depolymerizing with IC50 of 9.8~18 nM in tumor cells. Phase 1/2.

2013, 5(3):195-212